Stacy Berlekamp Spatar, NP-C
Nurse Practitioner in Reno, Nevada.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 87,700 in Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Stacy Berlekamp Spatar, NP-C reported a CMS MIPS final score of 91.6/100 - above the 83.1 national average - and filed 757 Medicare Part D claims in 2023.
- 91.6/100
- MIPS score · +8 vs avg
- 757
- Part D claims, 2023
- 98%
- generic prescribing
- $64.71
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Stacy Berlekamp Spatar, NP-C's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
92 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Stacy Berlekamp Spatar, NP-C sits
This provider among nurse practitioner peers
Across the 13,476 nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Stacy Berlekamp Spatar, NP-C writes more Part D claims than 65% of them and scores higher on MIPS quality than 65% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one nurse practitioner peer from a representative sample of 60; the gold marker is Stacy Berlekamp Spatar, NP-C. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Stacy Berlekamp Spatar, NP-C?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Nevada
How Nurse Practitioner compares to other specialties among Nevada providers
Nurse Practitioner ranks #28 among Nevada's specialties (0.8% of in-state providers)
Each bar is a specialty's share of the Nevada provider total, by primary NUCC taxonomy. The highlighted bar is Nurse Practitioner; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Stacy Berlekamp Spatar, NP-C's 2023 MIPS final score plotted against the Nurse Practitioner national average
- MIPS Final Score
- 91.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Nurse Practitioner) - 91.6/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Nurse Practitioner US NPIs
91.6/100 MIPS final score - 8.5 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Nurse Practitioner. Quality dim: 85.1.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Stacy Berlekamp Spatar, NP-C appears in the CMS NPPES registry as a Nurse Practitioner provider holding NP-C credentials at 9990 DOUBLE R BLVD STE 200, Reno, NV, 89521, with a listed phone of (775) 348-8800. NPI 1740622240 was issued on 07/24/2013.
Medicare Part D records for calendar year 2023 show 757 prescription claims written by this provider, covering 154 Medicare beneficiaries and totaling roughly $26K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 49.7%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.6/100 for the 2023 performance year (Quality 85.1), compared with the national average of 83.1.
Nurse Practitioner is a high-volume specialty nationwide, with 87,700 enrolled providers across 56 states and an average of 1,084 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1740622240 |
|---|---|
| Specialty | Nurse Practitioner |
| Credentials | NP-C |
| Gender | Female |
| NPI Issued | 07/24/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Stacy Berlekamp Spatar, NP-C's current license status, disciplinary history, and board certifications with the Nevada State Board of Medical Examiners in Nevada before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1740622240 is the unique 10-digit identifier CMS uses to link Berlekamp Spatar across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Stacy Berlekamp Spatar, NP-C. Source: openpaymentsdata.cms.gov.
Total received
$65
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 757 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 822
- Total Day Supply
- 22,960
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $11K
- Generic Drug Cost
- $15K
- Opioid Claims
- 376 (49.7% rate)
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 1.48
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 26, 65-74: 63, 75-84: 54, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Stacy Berlekamp Spatar, NP-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
147 claims
- Gabapentin
Gabapentin
111 claims
- Pregabalin
Pregabalin
75 claims
- Oxycodone Hcl
Oxycodone Hcl
65 claims
- Duloxetine Hcl
Duloxetine Hcl
62 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
59 claims
- Tramadol Hcl 40
Tramadol Hcl
40 claims
- Baclofen 19
Baclofen
19 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 147 |
| Gabapentin | 111 |
| Pregabalin | 75 |
| Oxycodone Hcl | 65 |
| Duloxetine Hcl | 62 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 59 |
| Tramadol Hcl | 40 |
| Baclofen | 19 |
| Trazodone Hcl | 17 |
| Cyclobenzaprine Hcl | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nurse Practitioner Overview
How Stacy Berlekamp Spatar, NP-C fits within the Nurse Practitioner landscape nationally.
Stacy Berlekamp Spatar, NP-C's 757 claims are below the specialty average of 1,084.
Nearby Nurse Practitioner Providers in Nevada
Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as Berlekamp Spatar.
Compare Nurse Practitioner nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Nevada medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Nurse Practitioner peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Nevada
Frequently Asked Questions
What is Stacy Berlekamp Spatar, NP-C's specialty? ▼
How much does Stacy Berlekamp Spatar, NP-C prescribe under Medicare Part D? ▼
What is Stacy Berlekamp Spatar, NP-C's Medicare quality score? ▼
Where is Stacy Berlekamp Spatar, NP-C located? ▼
What is Stacy Berlekamp Spatar, NP-C's NPI number? ▼
Does Stacy Berlekamp Spatar, NP-C prescribe more brand-name or generic drugs? ▼
Does Stacy Berlekamp Spatar, NP-C prescribe opioids? ▼
How many Nurse Practitioner providers are there in the US? ▼
What drugs does Stacy Berlekamp Spatar, NP-C prescribe most often? ▼
Does Stacy Berlekamp Spatar, NP-C accept Medicare? ▼
How can I verify Stacy Berlekamp Spatar, NP-C's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.